Environmental restrictions within tumor ecosystems select for a convergent, hypoxia-resistant phenotype of cancer stem cells

被引:28
作者
Olivotto, Massimo [1 ]
Dello Sbarba, Persio [1 ]
机构
[1] Univ Florence, Dept Expt Pathol & Oncol, Florence, Italy
关键词
tumor; ecosystems and cancer stem cells; hypoxia and cancer metabolism; cellular redox state; Warburg's theory revisited; folate; metabolism;
D O I
10.4161/cc.7.2.5315
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Tumors are ecosystems which develop from stem cells endowed with unlimited self-renewal and genetic instability, under the effects of mutagenesis and natural selection imposed by environmental changes. While changes and variations made possible by genetic instability are practically unlimited, the microenvironment progressively reduces those possibilities in the struggle for life imposed by hypoxia and nutrient shortage typical of tumor environments. This entails the tendency to evolve a convergent phenotype resistant to microenvironmental restrictions (first of all hypoxia), which progressively dominates the clonal selection. It is shown that adaptation to hypoxia, rather than being a peculiarity of cancer stem cells, is also a characteristic of normal hematopoietic stem cells, and may thus be described as a general feature of the stem cell phenotype. The metabolic orientation of this phenotype closely resembles the orientation of highly anaplastic ascites hepatomas, showing that, in restricted environments, stem cell recruitment to growth is limited by mitochondrial reoxidation of reducing equivalents produced in folate redox steps connected with purine synthesis. Finally, a review of earlier research into glucose metabolism in cancer leads to the reinterpretation of Warburg's aerobic glycolysis as a defence mechanism which disposes of glycolytic products able to negatively interfere with the crucial role of mitochondrial respiration in cell recruitment for growth.
引用
收藏
页码:176 / 187
页数:12
相关论文
共 75 条
[1]   Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: Novel pathways and targets for anticancer therapeutics [J].
Airley, Rachel E. ;
Mobasheri, Ali .
CHEMOTHERAPY, 2007, 53 (04) :233-256
[2]   Hypoxic upregulation of glucose transporters in BeWo choriocarcinoma cells is mediated by hypoxia-inducible factor-1 [J].
Baumann, Marc U. ;
Zamudio, Stacy ;
Illsley, Nicholas P. .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2007, 293 (01) :C477-C485
[3]   Cell renewing in neuroblastoma: Electrophysiological and immunocytochemical characterization of stem cells and derivatives [J].
Biagiotti, Tiziana ;
D'Amico, Massimo ;
Marzi, Ilaria ;
Di Gennaro, Paola ;
Arcangeli, Annarosa ;
Wanke, Enzo ;
Olivotto, Massimo .
STEM CELLS, 2006, 24 (02) :443-453
[4]   Antiangiogenic therapy and tumor progression [J].
Blagosklonny, MV .
CANCER CELL, 2004, 5 (01) :13-17
[5]   Carcinogenesis, cancer therapy and chemoprevention [J].
Blagosklonny, MV .
CELL DEATH AND DIFFERENTIATION, 2005, 12 (06) :592-602
[6]   Oncogenic resistance to growth-limiting conditions [J].
Blagosklonny, MV .
NATURE REVIEWS CANCER, 2002, 2 (03) :221-225
[7]   Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies [J].
Brown, JM .
MOLECULAR MEDICINE TODAY, 2000, 6 (04) :157-162
[8]  
Brown JM, 1998, CANCER RES, V58, P1408
[9]  
CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65
[10]  
CHENG KC, 1993, ADV CANCER RES, V60, P121